# US 6,353,038 B1 · Plastic based composite and its use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,353,038 B1
- Document ID: US6353038B1
- Status: Granted
- Kind: B1
- Application number: 09/446,630
- Filed: 2000-02-23
- Granted: 2002-03-05
- Earliest claimed: 1997-07-08
- Assignees: Bioxid Oy; JVS-Polymers Oy
- Inventors: Allan Aho; Jukka Seppälä; Antti Yli-Urpo; Jouni Heikkilä; Ilkka Kangasniemi
- Web page: https://patentgrep.com/patent/US6353038B1

## CPC

- A61L 27/446: {with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46}
- A61L 27/46: with phosphorus-containing inorganic fillers
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

A composite intended for medical use, in particular surgical or therapeutic use, characterized in that it comprises a mixture of a thermoplastic component plasticizable within the temperature range −10° . . . +100° C., which is substantially made up of hydroxy acids and structural units derived from hydroxy acid derivatives and the molar mass of which is within the range 30,000-1,000,000 g/mol, and which degrades in the body typically within a period ranging from a few days to several years, and which in its solid state is a mechanically strong plastic or rubbery material, and a bioactive component, which is a bioactive glass or a bioactive xerogel, such that the plasticized thermoplastic component remains moldable for a certain period even after the temperature of the composite has been lowered to a temperature which is considerably lower than the setting temperature of said thermoplastic component.

## Claims

### Claim 1

A composite intended for medical use, in particular surgical or therapeutic use, characterized in that it comprises a mixture of
a thermoplastic component plasticizable within the temperature range −10° . . . +100° C., which is substantially made up of hydroxy acids and structural units derived from hydroxy acid derivatives, and the molar mass of which is within the range 30,000-1,000,000 g/mol, and which degrades in the body typically within a period ranging from a few days to several years, and which in its solid state is a mechanically strong plastic or rubbery material, and
a bioactive component, which is a bioactive glass or a bioactive xerogel,
such that the plasticized thermoplastic component remains moldable for a certain period even after the temperature of the composite has been lowered to a temperature which is considerably lower than the setting temperature of said thermoplastic component.

### Claim 2 (depends on 1)

The composite according to claim 1, characterized in that the plastic component is plasticizable within the temperature range 5° C. . . . 70° C., preferably within the temperature range 37° C. . . . 55° C.

### Claim 3 (depends on 1)

The composite according to claim 1, characterized in that the plastic component is biodegradable in a controlled manner within the time range 1 week-3 years.

### Claim 4 (depends on 3)

The composite according to claim 3, characterized in that the structural unit is an L-, D- or DL-lactic acid; an L-, D- or DL-lactide; or epsilon-caprolactone.

### Claim 5 (depends on 4)

The composite according to claim 4, characterized in that the plastic component is a copolymer based on structural units of L-lactide and epsilon-caprolactone.

### Claim 6 (depends on 5)

The composite according to claim 5, characterized in that the composition of the copolymer is within the range epsilon ⁢ - ⁢ caprolactone L ⁢ - ⁢ lactide = 2 / 98 ⁢ ⁢ … ⁢ ⁢ 98 / 2

### Claim 7 (depends on 6)

The composite according to claim 6, characterized in that epsilon ⁢ - ⁢ caprolactone L ⁢ - ⁢ lactide = 4 : 1

### Claim 8 (depends on 7)

The composite according to claim 7, characterized in that the molar mass of the copolymer is approx. 30,000-300,000 g/mol.

### Claim 9 (depends on 1)

The composite according to claim 1, characterized in that the bioactive component is present as separate particles in the composite.

### Claim 10 (depends on 9)

The composite according to claim 9, characterized in that the separate particles are fibers, porous pieces, microparticles or glass beads.

### Claim 11 (depends on 1)

The composite according to claim 1, characterized in that the plastic component and/or the bioactive component contains one or more additives.

### Claim 12 (depends on 1)

The composite according to claim 1, characterized in that the plastic component and the bioactive component form a dense piece.

### Claim 13 (depends on 1)

The composite according to claim 1, characterized in that the plastic component forms a porous piece.

### Claim 14 (depends on 1)

A blend intended for the preparation of a composite according to claim 1, characterized in that the plastic component and the bioactive component in the blend are in powder form.

### Claim 15 (depends on 1)

A coating, membrane, net, powder, fiber, thread, adhesive, or a piece such as a plate, bead, tube, nail or rod, prepared from the composite according to claim 1.

### Claim 16 (depends on 1)

The composite of claim 1, wherein the plasticized thermoplastic component remains moldable for a certain period even after the temperature of the composite has been lowered to a temperature approximately 10 to 15° C. lower than the setting temperature of said thermoplastic component.

### Claim 17 (depends on 1)

The composite of claim 1, wherein said certain period is from 15 seconds to 30 minutes.
